|
Volumn 24, Issue 6, 2006, Pages 597-
|
First in class stimulates natural killer cells
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
MONOCLONAL ANTIBODY;
RECOMBINANT INTERLEUKIN 2;
IMMUNOGLOBULIN RECEPTOR;
ACUTE GRANULOCYTIC LEUKEMIA;
ADVANCED CANCER;
AUTOIMMUNE DISEASE;
BONE MARROW TRANSPLANTATION;
CANCER;
CANCER CHEMOTHERAPY;
CELL STIMULATION;
CLINICAL TRIAL;
GRAFT REJECTION;
GRAFT VERSUS HOST REACTION;
HEMATOLOGIC MALIGNANCY;
HUMAN;
INFECTION;
LEUKEMIA RELAPSE;
NATURAL KILLER CELL;
NONHUMAN;
NOTE;
OPPORTUNISTIC INFECTION;
PRIORITY JOURNAL;
ANIMAL;
ARTICLE;
CELL COMMUNICATION;
HISTOCOMPATIBILITY;
IMMUNOLOGY;
IMMUNOTHERAPY;
METHODOLOGY;
NEOPLASM;
TRANSPLANTATION;
ANIMALS;
CELL COMMUNICATION;
HUMANS;
IMMUNOTHERAPY;
KILLER CELLS, NATURAL;
NEOPLASMS;
RECEPTORS, IMMUNOLOGIC;
TRANSPLANTATION IMMUNOLOGY;
|
EID: 33745059906
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0606-597 Document Type: Note |
Times cited : (23)
|
References (0)
|